Observation of curative effection of Milli Fire Needle in treating Localized Scleroderma
Phase 1
Recruiting
- Conditions
- ocalized Scleroderma
- Registration Number
- ITMCTR2100004289
- Lead Sponsor
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Aged between 18~70 years;
2. Diagnosed as morphea by over three experienced dermatologists or biopsy;
3. Skin Thickness score two or more;
4. Willing to accept Milli Fire Needle therapy.
Exclusion Criteria
1. Pregnancy or lactation;
2. Used to be fainting during acupuncture treatment;
3. Prior to hypertension, diabetes, heart failure;
4. Active infection or ulcer of the lesion.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which Milli Fire Needle therapy exerts its effects on localized scleroderma?
How does the efficacy of Milli Fire Needle compare to standard-of-care treatments like methotrexate or mycophenolate in localized scleroderma?
Are there specific biomarkers that can predict patient response to Milli Fire Needle treatment in localized scleroderma subtypes such as morphea or linear scleroderma?
What are the potential adverse events associated with Milli Fire Needle therapy and how can they be managed in localized scleroderma patients?
What are the current combination approaches or competitor therapies being explored for localized scleroderma treatment alongside traditional Chinese medicine interventions like Milli Fire Needle?